NASDAQ:RCKT
Rocket Pharmaceuticals Inc Stock News
$23.47
+0.700 (+3.07%)
At Close: May 03, 2024
Rocket Pharmaceuticals Announces Participation at Upcoming Conferences
07:00am, Thursday, 18'th Feb 2021
CRANBURY, N.J.--(BUSINESS WIRE)---- $RCKT #GeneTherapy--Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT), a clinical-stage company advancing an integrated and sustainable pipeline of genetic therapies for
Rocket Pharmaceuticals: Moving Closer To A Potential Launch
12:07pm, Thursday, 11'th Feb 2021
Rocket recently released impressive data for their gene therapy candidate for Danon Disease, RP-A501. The data demonstrated that RP-A501 was able to improve some of the hallmark metrics and symptoms.
Reddit playing a major role in biotech trading action, says Jefferies top health care analyst
06:11pm, Thursday, 04'th Feb 2021
Jared Holz, Jefferies managing director and healthcare sector specialist, on which biotech stocks could be the next targets. With Melissa Lee and the Fast Money traders, Guy Adami, Tim Seymour, Karen
CRANBURY, N.J.--(BUSINESS WIRE)---- $RCKT #GeneTherapy--Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT), a clinical-stage company advancing an integrated and sustainable pipeline of genetic therapies for
Rocket Pharmaceuticals Announces Participation at the 39th Annual J.P. Morgan Healthcare Conference
07:00am, Wednesday, 06'th Jan 2021
NEW YORK--(BUSINESS WIRE)---- $RCKT #GeneTherapy--Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) (“Rocket”), a clinical-stage company advancing an integrated and sustainable pipeline of genetic thera
5 Medical Outperformers That Might Lose Steam in 2021
10:32am, Tuesday, 22'nd Dec 2020
Here we discuss some biotech stocks, which are up this year so far but might not be good additions to your portfolio.
NEW YORK--(BUSINESS WIRE)---- $RCKT #GeneTherapy--Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) (“Rocket”), a clinical-stage company advancing an integrated and sustainable pipeline of genetic thera
Rocket Pharmaceuticals Prices Upsized Public Offering of Common Stock
11:32pm, Wednesday, 09'th Dec 2020
NEW YORK--(BUSINESS WIRE)---- $RCKT #GeneTherapy--Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) (“Rocket”), a clinical-stage company advancing an integrated and sustainable pipeline of genetic thera
These Biotech Stock Market Winners Have Nothing to Do With COVID-19
06:01pm, Wednesday, 09'th Dec 2020
You don't have to be a pandemic fighter to have a big victory for investors.
Rocket Pharmaceuticals Announces Proposed Public Offering of Common Stock
07:51am, Wednesday, 09'th Dec 2020
NEW YORK--(BUSINESS WIRE)---- $RCKT #GeneTherapy--Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) (“Rocket”), a clinical-stage company advancing an integrated and sustainable pipeline of genetic thera
NEW YORK--(BUSINESS WIRE)---- $RCKT #Danon--Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) (“Rocket”), a clinical-stage company advancing an integrated and sustainable pipeline of genetic therapies f
NEW YORK--(BUSINESS WIRE)---- $RCKT #ASH2020--Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) (“Rocket”), a clinical-stage company advancing an integrated and sustainable pipeline of genetic therapies
NEW YORK--(BUSINESS WIRE)---- $RCKT #ASH2020--Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) (“Rocket”), a clinical-stage company advancing an integrated and sustainable pipeline of genetic therapies
Rocket Pharmaceuticals to Hold Webcast for Investors Highlighting Data Presented at the 62nd American Society of Hematology Annual Meeting
07:00am, Wednesday, 02'nd Dec 2020
NEW YORK--(BUSINESS WIRE)---- $RCKT #GeneTherapy--Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) (“Rocket”), a clinical-stage company advancing an integrated and sustainable pipeline of genetic thera
NEW YORK--(BUSINESS WIRE)---- $RCKT #GeneTherapy--Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) (“Rocket”), a clinical-stage company advancing an integrated and sustainable pipeline of genetic thera
